PFN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.965400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.125600E-01
Normal-vs-Stage2
8.144600E-01
Normal-vs-Stage3
8.242600E-01
Normal-vs-Stage4
6.835200E-01
Stage1-vs-Stage2
6.175600E-01
Stage1-vs-Stage3
4.178400E-01
Stage1-vs-Stage4
9.508000E-01
Stage2-vs-Stage3
5.589400E-01
Stage2-vs-Stage4
6.208800E-01
Stage3-vs-Stage4
5.194000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.818600E-01
Normal-vs-AfricanAmerican
4.458000E-01
Normal-vs-Asian
8.002200E-01
Caucasian-vs-AfricanAmerican
6.524000E-01
Caucasian-vs-Asian
2.643800E-01
AfricanAmerican-vs-Asian
1.366010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.283600E-01
Normal-vs-Female
6.319000E-01
Male-vs-Female
9.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.632600E-01
Normal-vs-Age(41-60Yrs)
4.691400E-01
Normal-vs-Age(61-80Yrs)
7.577400E-01
Normal-vs-Age(81-100Yrs)
6.338600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.753800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.805800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.024400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.568000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.162330E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.800500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.341000E-01
Normal-vs-Daily Drinker
7.897600E-01
Normal-vs-Weekly Drinker
9.063400E-01
Normal-vs-Occasional Drinker
3.401400E-01
Normal-vs-Social Drinker
5.200200E-01
Non Drinker-vs-Daily Drinker
1.069610E-01
Non Drinker-vs-Weekly Drinker
3.969800E-01
Non Drinker-vs-Occasional Drinker
7.622000E-03
Non Drinker-vs-Social Drinker
4.973900E-02
Daily Drinker-vs-Weekly Drinker
4.815800E-01
Daily Drinker-vs-Occasional Drinker
8.527600E-02
Daily Drinker-vs-Social Drinker
3.416000E-01
Weekly Drinker-vs-Occasional Drinker
2.764300E-02
Weekly Drinker-vs-Social Drinker
1.505440E-01
Occasional Drinker-vs-Social Drinker
4.430600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.545000E-01
Normal-vs-Grade 2
3.826800E-01
Normal-vs-Grade 3
3.037600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.810600E-01
Grade 1-vs-Grade 3
4.083200E-01
Grade 1-vs-Grade 4
4.545000E-01
Grade 2-vs-Grade 3
6.447800E-01
Grade 2-vs-Grade 4
3.826800E-01
Grade 3-vs-Grade 4
3.037600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.747400E-01
Normal-vs-NonDiabetic
6.691200E-01
Diabetic-vs-NonDiabetic
1.057570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.311000E-01
Normal-vs-NoPancreatitis
7.289200E-01
Pancreatitis-vs-NoPancreatitis
9.152800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.160000E-01
Normal-vs-N1
7.738800E-01
N0-vs-N1
1.917570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.294000E-01
Normal-vs-TP53-NonMutant
5.594000E-01
TP53-Mutant-vs-TP53-NonMutant
3.980200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
